JP2019506866A5 - - Google Patents

Download PDF

Info

Publication number
JP2019506866A5
JP2019506866A5 JP2018540841A JP2018540841A JP2019506866A5 JP 2019506866 A5 JP2019506866 A5 JP 2019506866A5 JP 2018540841 A JP2018540841 A JP 2018540841A JP 2018540841 A JP2018540841 A JP 2018540841A JP 2019506866 A5 JP2019506866 A5 JP 2019506866A5
Authority
JP
Japan
Prior art keywords
igg
polypeptide
protease activity
cysteine protease
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018540841A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019506866A (ja
JP7123801B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/052463 external-priority patent/WO2017134274A1/en
Publication of JP2019506866A publication Critical patent/JP2019506866A/ja
Publication of JP2019506866A5 publication Critical patent/JP2019506866A5/ja
Priority to JP2022056522A priority Critical patent/JP2022115853A/ja
Application granted granted Critical
Publication of JP7123801B2 publication Critical patent/JP7123801B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018540841A 2016-02-04 2017-02-03 新しい連鎖球菌プロテアーゼ Active JP7123801B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022056522A JP2022115853A (ja) 2016-02-04 2022-03-30 新しい連鎖球菌プロテアーゼ

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1630021 2016-02-04
SE1630021-2 2016-02-04
PCT/EP2017/052463 WO2017134274A1 (en) 2016-02-04 2017-02-03 New streptococcal proteases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022056522A Division JP2022115853A (ja) 2016-02-04 2022-03-30 新しい連鎖球菌プロテアーゼ

Publications (3)

Publication Number Publication Date
JP2019506866A JP2019506866A (ja) 2019-03-14
JP2019506866A5 true JP2019506866A5 (https=) 2020-03-12
JP7123801B2 JP7123801B2 (ja) 2022-08-23

Family

ID=57995190

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018540841A Active JP7123801B2 (ja) 2016-02-04 2017-02-03 新しい連鎖球菌プロテアーゼ
JP2022056522A Withdrawn JP2022115853A (ja) 2016-02-04 2022-03-30 新しい連鎖球菌プロテアーゼ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022056522A Withdrawn JP2022115853A (ja) 2016-02-04 2022-03-30 新しい連鎖球菌プロテアーゼ

Country Status (13)

Country Link
US (1) US12006530B2 (https=)
EP (1) EP3411389B1 (https=)
JP (2) JP7123801B2 (https=)
KR (1) KR102704583B1 (https=)
CN (1) CN109311951B (https=)
AU (1) AU2017214441B2 (https=)
CA (1) CA3013527C (https=)
DK (1) DK3411389T3 (https=)
ES (1) ES2877754T3 (https=)
PL (1) PL3411389T3 (https=)
PT (1) PT3411389T (https=)
SG (1) SG11201806639VA (https=)
WO (1) WO2017134274A1 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12546782B2 (en) 2013-03-15 2026-02-10 Mayo Foundation For Medical Education And Research Identification and monitoring of monoclonal immunoglobulins related to monoclonal gammopathy by molecular mass with mass spectrometry
CA2944767C (en) 2014-04-04 2022-07-12 Mayo Foundation For Medical Education And Research Isotyping immunoglobulins using accurate molecular mass
EP3353200A4 (en) 2015-09-24 2019-06-26 Mayo Foundation for Medical Education and Research IDENTIFICATION OF FREE LIGHT CHAINS FROM IMMOBILIZED LOBULIN BY MASS SPECTROMETRY
AU2017214441B2 (en) 2016-02-04 2021-08-19 Genovis Ab New Streptococcal proteases
AU2017325022B2 (en) 2016-09-07 2022-10-13 Mayo Foundation For Medical Education And Research Identification and monitoring of cleaved immunoglobulins by molecular mass
CN111183220B (zh) 2017-05-26 2024-03-22 杰诺维斯公司 用于聚糖分析的工具
US20210228738A1 (en) 2017-07-17 2021-07-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins
US12153052B2 (en) 2017-09-13 2024-11-26 Mayo Foundation For Medical Education And Research Identification and monitoring of immunoglobulin J chains
US11946937B2 (en) 2017-09-13 2024-04-02 Mayo Foundation For Medical Education And Research Identification and monitoring of apoptosis inhibitor of macrophage
EP3723794A1 (en) * 2017-12-15 2020-10-21 Intervet International B.V. A vaccine for protection against streptococcus suis
WO2021067598A1 (en) 2019-10-04 2021-04-08 Ultragenyx Pharmaceutical Inc. Methods for improved therapeutic use of recombinant aav
JP2023514204A (ja) 2020-02-14 2023-04-05 ウルトラジェニックス ファーマシューティカル インコーポレイテッド Cdkl5欠損障害を処置するための遺伝子治療
GB202002072D0 (en) * 2020-02-14 2020-04-01 Hansa Biopharma AB immunoglobulin detection and associated therapies
WO2021254479A1 (zh) * 2020-06-18 2021-12-23 上海宝济药业有限公司 一种免疫球蛋白降解酶IdeE的突变体
CA3195177A1 (en) 2020-10-07 2022-04-14 Asklepios Biopharmaceutical, Inc. Therapeutic adeno-associated virus delivery of fukutin related protein (fkrp) for treating dystroglycanopathy disorders including limb girdle 2i (lgmd2i)
WO2022221529A1 (en) 2021-04-16 2022-10-20 Asklepios Biopharmaceutical, Inc. Rational polyploid aav virions that cross the blood brain barrier and elicit reduced humoral response
EP4079848A1 (en) 2021-04-22 2022-10-26 Genovis Ab Immunoglobulin cleaving enzyme
US20240271115A1 (en) * 2021-06-15 2024-08-15 The University Of North Carolina At Chapel Hill Methods and compositions for depleting antibodies
US20250019721A1 (en) 2021-08-11 2025-01-16 Ultragenyx Pharmaceutical Inc. Compositions and methods for treating a muscular dystrophy
US20240424077A1 (en) * 2021-11-18 2024-12-26 Intervet Inc. A method to produce a vaccine against streptococcus suis and the said vaccine
JPWO2024111657A1 (https=) * 2022-11-25 2024-05-30
JPWO2025047641A1 (https=) * 2023-08-25 2025-03-06
WO2025256977A1 (en) 2024-06-13 2025-12-18 Bayer Aktiengesellschaft Novel igm and igg cleaving enzymes
WO2025256978A1 (en) 2024-06-13 2025-12-18 Bayer Aktiengesellschaft Variants of igm and igg cleaving enzymes
GB202413764D0 (en) 2024-09-18 2024-10-30 Genovis Ab Immunoglobulin proteases and their uses

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2824074A1 (fr) * 2001-04-26 2002-10-31 Pasteur Institut Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
GB0130228D0 (en) 2001-12-18 2002-02-06 Hansa Medica Ab Protein
JP2008525033A (ja) 2004-12-22 2008-07-17 ノバルティス ヴァクシンズ アンド ダイアグノスティクス, インコーポレイテッド B群連鎖球菌
PL1901773T3 (pl) 2005-06-09 2012-09-28 Hansa Medical Ab Zastosowanie proteinazy IDES (Z S. Pyogenes) do leczenia chorób autoimmunologicznych oraz odrzutów przeszczepu
DK2190984T3 (da) 2007-09-14 2013-12-02 Genovis Ab Fremgangsmåder og kits til oprensning og påvisning af glycosyleret IgG
GB201115841D0 (en) * 2011-09-13 2011-10-26 Genovis Ab Protein and method
GB201316744D0 (en) 2013-09-20 2013-11-06 Genovis Ab Method
AU2017214441B2 (en) 2016-02-04 2021-08-19 Genovis Ab New Streptococcal proteases

Similar Documents

Publication Publication Date Title
JP2019506866A5 (https=)
JP2014531205A5 (https=)
Cid-Uribe et al. The diversity of venom components of the scorpion species Paravaejovis schwenkmeyeri (Scorpiones: Vaejovidae) revealed by transcriptome and proteome analyses
KR20130135028A (ko) 동물로부터 단일클론 항체의 고속 분리
PH12015502849B1 (en) Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers
WO2015112558A3 (en) Peptides, devices, and methods for the detection of anaplasma antibodies
FI20165814A7 (fi) Interleukiini 8 (il-8) prognostisena ja ennustavana biomarkkerina ja koostumukset ja vektorit käytettäväksi onkolyyttisessa immunoterapiassa
FI20165634A7 (fi) Laite ja menetelmät mikro-organismien identifioimiseksi häiritsevästä matriisista
EP4675278A3 (en) Assay for plasma cell associated disease
JP2019507341A5 (https=)
FI3630967T3 (fi) Proteaasi ja sitoutuva polypeptidi o-glykoproteiineja varten
JP2020522242A5 (https=)
Qiu et al. Identification of a TNF-α inducer MIC3 originating from the microneme of non-cystogenic, virulent Toxoplasma gondii
CA2982706A1 (en) Automatable method for nucleic acid isolation
WO2017125892A3 (es) Anticuerpos monoclonales específicos para el antígeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por adv
Schröder Discovery of natural bispecific antibodies: Is psoriasis induced by a toxigenic Corynebacterium simulans and maintained by CIDAMPs as autoantigens?
CN108276480A (zh) Pcv3抗原表位的多肽序列筛选方法
Matysiak et al. Association between venom immunotherapy and changes in serum protein—Peptide patterns
CN103772509A (zh) 一种艰难梭菌毒素a/b的融合蛋白及其编码基因与应用
SG10201903424RA (en) ANTI HUMAN Gas6 MONOCLONAL ANTIBODY
GB2541596A (en) Method and composition for determining specific antibody responses to species of filovirus
Reed et al. Novel mass spectrometry based detection and identification of variants of rabies virus nucleoprotein in infected brain tissues
De Filette et al. T cell epitope mapping of the e-protein of West Nile virus in BALB/c mice
WO2013042917A3 (ko) 중공사막을 이용한 단백질의 효소 처리장치 및 이를 이용한 온-라인 프로테오믹스 방법
US9284360B2 (en) Diagnostic test for infectious diseases in cattle